These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31467179)

  • 1.
    Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
    Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Ganaie AA; Beigh FH; Astone M; Ferrari MG; Maqbool R; Umbreen S; Parray AS; Siddique HR; Hussain T; Murugan P; Morrissey C; Koochekpour S; Deng Y; Konety BR; Hoeppner LH; Saleem M
    Clin Cancer Res; 2018 Dec; 24(24):6421-6432. PubMed ID: 30087142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent nuclear ERG and MYC protein overexpression defines a subset of locally advanced prostate cancer: Potential opportunities for synergistic targeted therapeutics.
    Udager AM; DeMarzo AM; Shi Y; Hicks JL; Cao X; Siddiqui J; Jiang H; Chinnaiyan AM; Mehra R
    Prostate; 2016 Jun; 76(9):845-53. PubMed ID: 27159573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMI1 polycomb group protein acts as a master switch for growth and death of tumor cells: regulates TCF4-transcriptional factor-induced BCL2 signaling.
    Siddique HR; Parray A; Tarapore RS; Wang L; Mukhtar H; Karnes RJ; Deng Y; Konety BR; Saleem M
    PLoS One; 2013; 8(5):e60664. PubMed ID: 23671559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.
    Wang HB; Liu GH; Zhang H; Xing S; Hu LJ; Zhao WF; Xie B; Li MZ; Zeng BH; Li Y; Zeng MS
    FEBS J; 2013 Jun; 280(12):2929-44. PubMed ID: 23601184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
    Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
    Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
    Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
    J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
    Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
    J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
    Pan H; Zhu Y; Wei W; Shao S; Rui X
    World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1-C activates BMI1 in human cancer cells.
    Hiraki M; Maeda T; Bouillez A; Alam M; Tagde A; Hinohara K; Suzuki Y; Markert T; Miyo M; Komura K; Ahmad R; Rajabi H; Kufe D
    Oncogene; 2017 May; 36(20):2791-2801. PubMed ID: 27893710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
    Nacerddine K; Beaudry JB; Ginjala V; Westerman B; Mattiroli F; Song JY; van der Poel H; Ponz OB; Pritchard C; Cornelissen-Steijger P; Zevenhoven J; Tanger E; Sixma TK; Ganesan S; van Lohuizen M
    J Clin Invest; 2012 May; 122(5):1920-32. PubMed ID: 22505453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway.
    Cho JH; Dimri M; Dimri GP
    J Biol Chem; 2013 Feb; 288(5):3406-18. PubMed ID: 23239878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAGE-C2/CT10 promotes growth and metastasis through upregulating c-Myc expression in prostate cancer.
    Qiu J; Yang B
    Mol Cell Biochem; 2021 Jan; 476(1):1-10. PubMed ID: 32935296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
    Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
    Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression.
    Zhao M; Qi M; Li X; Hu J; Zhang J; Jiao M; Bai X; Peng X; Han B
    Prostate; 2019 Apr; 79(5):480-488. PubMed ID: 30609075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bmi1 drives stem-like properties and is associated with migration, invasion, and poor prognosis in tongue squamous cell carcinoma.
    He Q; Liu Z; Zhao T; Zhao L; Zhou X; Wang A
    Int J Biol Sci; 2015; 11(1):1-10. PubMed ID: 25552924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCAPG2 promotes prostate cancer malignancy and stemness via STAT3/c-MYC signaling.
    Zhang E; Chen Z; Liu W; Lin L; Wu L; Guan J; Wang J; Kong C; Bi J; Zhang M
    J Transl Med; 2024 Jan; 22(1):12. PubMed ID: 38166947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.